Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 9: | Line 9: | ||
! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | ! colspan="2" rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Mechanism | ||
! colspan="12" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations | ! colspan="12" rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical manifestations | ||
! colspan=" | ! colspan="10" align="center" style="background:#4479BA; color: #FFFFFF;" + |Paraclinical findings | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gold standard | ||
! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ! rowspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" + |Associated findings | ||
|- | |- | ||
! colspan=" | ! colspan="9" align="center" style="background:#4479BA; color: #FFFFFF;" + |Lab findings | ||
! | ! rowspan="3" |Imaging | ||
|- | |- | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Demography | ||
Line 25: | Line 25: | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |PT/PTT | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |PT/PTT | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Immunochemistry | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Histopathology | ||
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Other | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Inherited | ||
Line 46: | Line 44: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Plt | ||
|- | |- | ||
! colspan=" | ! colspan="29" align="left" style="background:#4479BA; color: #FFFFFF;" + |HL | ||
|- | |- | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ! align="center" style="background:#4479BA; color: #FFFFFF;" + | | ||
! align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ! align="center" style="background:#DCDCDC;" + |Hodgkin's Lymphoma | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
Line 79: | Line 76: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
|- | |- | ||
! colspan=" | ! colspan="29" align="left" style="background:#4479BA; color: #FFFFFF;" + |NHL | ||
|- | |- | ||
! | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |B Cell Lymphoma | ||
! align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ! align="center" style="background:#DCDCDC;" + |Precursor B-cell lymphoblastic leukemia/lymphoma | ||
| | | | ||
* Precursor B-cell Lymphoma | * Precursor B-cell Lymphoma | ||
| | | | ||
| | | | ||
Line 114: | Line 110: | ||
| | | | ||
|- | |- | ||
! | |||
|[[Follicular lymphoma]] | |[[Follicular lymphoma]] | ||
| | | | ||
Line 144: | Line 141: | ||
*[[Cough]] | *[[Cough]] | ||
*[[Dyspnea]] | *[[Dyspnea]] | ||
| | | | ||
| | | | ||
Line 158: | Line 154: | ||
| | | | ||
|- | |- | ||
! | |||
|Mantle cell lymphoma | |Mantle cell lymphoma | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | | ||
| | | | ||
Line 189: | Line 185: | ||
| | | | ||
|- | |- | ||
! | |||
|Diffuse large B cell lymphoma | |Diffuse large B cell lymphoma | ||
| | | | ||
Line 219: | Line 216: | ||
| | | | ||
* | * | ||
| | | | ||
| | | | ||
Line 238: | Line 234: | ||
| | | | ||
|- | |- | ||
!Category | |||
| | |Disease | ||
|Etiology | |||
| | !Inherited | ||
!Acquired | |||
|Demography | |||
| | |History | ||
| | !Constitutional symptoms | ||
!Rash | |||
!Abdominal pain | |||
!Diarrhea | |||
!V/S | |||
!Mass | |||
!LAP | |||
!Hepatosplenomegaly | |||
!Arthritis | |||
!Other | |||
!WBC | |||
!Hb | |||
!Plt | |||
|PBS | |||
| | |LFT | ||
| | |PT/PTT | ||
| | |Immunochemistry | ||
| | |Histopathology | ||
| | |Other lab findings | ||
| | |Imaging | ||
| | |Gold standard | ||
| | |Associated findings | ||
| | |||
|- | |- | ||
! | |||
|[[Burkitt lymphoma]] | |[[Burkitt lymphoma]] | ||
| | | | ||
* Translocation of chromosome 8 ''[[myc]]'' locus | * Mature B-cell Lymphoma | ||
** | * Translocation of chromosome 8 ''[[myc]]'' locus such as: | ||
** | ** t(8;14) | ||
** | ** t(2;8) | ||
** t(8;22) | |||
| | | | ||
| | | | ||
Line 283: | Line 280: | ||
* [[Night sweats]] | * [[Night sweats]] | ||
* Unexplained [[weight loss]] | * Unexplained [[weight loss]] | ||
| | | | ||
| | | | ||
Line 297: | Line 293: | ||
* [[Lymphadenopathy|Peripheral lymphadenopathy]] | * [[Lymphadenopathy|Peripheral lymphadenopathy]] | ||
| | | | ||
* [[Swollen lymph nodes]] in the neck, axilla, or groin | |||
| | | | ||
| | | | ||
Line 313: | Line 310: | ||
* BCL6. | * BCL6. | ||
* BCL2 and TdT. | * BCL2 and TdT. | ||
| | | | ||
:* Medium-sized (~1.5-2x the size of a RBC) with uniform size ("monotonous") -- '''key feature''' (i.e. tumor nuclei size similar to that of [[histiocytes]] or [[endothelial cells]]) | :* Medium-sized (~1.5-2x the size of a RBC) with uniform size ("monotonous") -- '''key feature''' (i.e. tumor nuclei size similar to that of [[histiocytes]] or [[endothelial cells]]) | ||
Line 329: | Line 325: | ||
| | | | ||
|- | |- | ||
! | |||
|B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | |B cell chronic lymphocytic leukemia/small lymphocytic lymphoma | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | | ||
| | | | ||
Line 360: | Line 356: | ||
| | | | ||
|- | |- | ||
! | |||
|Marginal zone lymphoma | |Marginal zone lymphoma | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | | ||
| | | | ||
Line 391: | Line 387: | ||
| | | | ||
|- | |- | ||
! | |||
|Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | |Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) | ||
| | | | ||
* Mature B-cell Lymphoma | * Mature B-cell Lymphoma | ||
| | | | ||
| | | | ||
Line 455: | Line 451: | ||
| | | | ||
| | | | ||
| | |CBC | ||
* Anemia and cytopenias are secondary to bone marrow infiltration | |||
* Lymphocytosis > 4000/µL | |||
* Elevated LDH | |||
* | |||
| | | | ||
| | | | ||
Line 468: | Line 468: | ||
** CD22 | ** CD22 | ||
* Cyclin D1 is overexpressed. | * Cyclin D1 is overexpressed. | ||
| | | | ||
* Germinal centers filled by small-to-medium atypical lymphocytes. | * Germinal centers filled by small-to-medium atypical lymphocytes. | ||
Line 520: | Line 515: | ||
* AE1/AE3 | * AE1/AE3 | ||
* B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 are expressed | * B-cell markers CD20, CD79a, CD10, CD23, and bcl-2 are expressed | ||
| | | | ||
* Follicular cells in reactive zone | * Follicular cells in reactive zone | ||
Line 557: | Line 551: | ||
* [[CD20]] | * [[CD20]] | ||
* [[CD79a]] | * [[CD79a]] | ||
| | | | ||
* [[B-cells]] replace the normal [[white pulp]] of the [[spleen]]. | * [[B-cells]] replace the normal [[white pulp]] of the [[spleen]]. | ||
Line 607: | Line 600: | ||
| | | | ||
| | | | ||
* Tartrate-resistant acid phosphatase positive | |||
* CBC | |||
** Decreased [[hemoglobin]] concentration | |||
** Decreased [[platelets]] count | |||
** | |||
| | | | ||
| | | | ||
Line 620: | Line 618: | ||
* [[CD11c]] | * [[CD11c]] | ||
* [[FMC7]] | * [[FMC7]] | ||
| | | | ||
:* Small cells with "fried egg"-like appearance | :* Small cells with "fried egg"-like appearance | ||
Line 638: | Line 630: | ||
|- | |- | ||
|[[Multiple myeloma|Plasma cell myeloma]] | |[[Multiple myeloma|Plasma cell myeloma]] | ||
| | | | ||
| | | | ||
Line 668: | Line 659: | ||
|- | |- | ||
|[[Chronic lymphocytic leukemia]] / [[Chronic lymphocytic leukemia|small lymphocytic lymphoma]] | |[[Chronic lymphocytic leukemia]] / [[Chronic lymphocytic leukemia|small lymphocytic lymphoma]] | ||
| | | | ||
| | | | ||
Line 698: | Line 688: | ||
|- | |- | ||
|[[Monoclonal B-cell lymphocytosis]] | |[[Monoclonal B-cell lymphocytosis]] | ||
| | | | ||
| | | | ||
Line 728: | Line 717: | ||
|- | |- | ||
|[[B-cell prolymphocytic leukemia]] | |[[B-cell prolymphocytic leukemia]] | ||
| | | | ||
| | | | ||
Line 758: | Line 746: | ||
|- | |- | ||
|[[Waldenström's macroglobulinemia|Waldenström's macroglubulinemia]] | |[[Waldenström's macroglobulinemia|Waldenström's macroglubulinemia]] | ||
| | | | ||
| | | | ||
Line 788: | Line 775: | ||
|- | |- | ||
|[[Monoclonal gammopathy of undetermined significance]] (MGUS) | |[[Monoclonal gammopathy of undetermined significance]] (MGUS) | ||
| | | | ||
| | | | ||
Line 818: | Line 804: | ||
|- | |- | ||
|[[Heavy chain disease]] | |[[Heavy chain disease]] | ||
| | | | ||
| | | | ||
Line 848: | Line 833: | ||
|- | |- | ||
|Solitary plasmacytoma of bone | |Solitary plasmacytoma of bone | ||
| | | | ||
| | | | ||
Line 878: | Line 862: | ||
|- | |- | ||
|Extraosseous plasmacytoma | |Extraosseous plasmacytoma | ||
| | | | ||
| | | | ||
Line 908: | Line 891: | ||
|- | |- | ||
|Monoclonal immunoglobulin deposition diseases | |Monoclonal immunoglobulin deposition diseases | ||
| | | | ||
| | | | ||
Line 938: | Line 920: | ||
|- | |- | ||
|Extranodal marginal zone lymphoma of [[MALT lymphoma|mucosa-associated lymphoid tissue]] (MALT lymphoma) | |Extranodal marginal zone lymphoma of [[MALT lymphoma|mucosa-associated lymphoid tissue]] (MALT lymphoma) | ||
| | | | ||
| | | | ||
Line 968: | Line 949: | ||
|- | |- | ||
|Large B-cell lymphoma with IRF4 rearrangement | |Large B-cell lymphoma with IRF4 rearrangement | ||
| | | | ||
| | | | ||
Line 998: | Line 978: | ||
|- | |- | ||
|[[Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle center lymphoma]] | |[[Primary cutaneous follicle centre lymphoma|Primary cutaneous follicle center lymphoma]] | ||
| | | | ||
| | | | ||
Line 1,028: | Line 1,007: | ||
|- | |- | ||
|T-cell/histiocyte-rich large B-cell lymphoma | |T-cell/histiocyte-rich large B-cell lymphoma | ||
| | | | ||
| | | | ||
Line 1,058: | Line 1,036: | ||
|- | |- | ||
|[[Lymphomatoid granulomatosis]] | |[[Lymphomatoid granulomatosis]] | ||
| | | | ||
| | | | ||
Line 1,088: | Line 1,065: | ||
|- | |- | ||
|[[Primary mediastinal large B-cell lymphoma|Primary mediastinal (thymic) large B-cell lymphoma]] | |[[Primary mediastinal large B-cell lymphoma|Primary mediastinal (thymic) large B-cell lymphoma]] | ||
| | | | ||
| | | | ||
Line 1,118: | Line 1,094: | ||
|- | |- | ||
|[[Intravascular large B-cell lymphoma]] | |[[Intravascular large B-cell lymphoma]] | ||
| | | | ||
| | | | ||
Line 1,148: | Line 1,123: | ||
|- | |- | ||
|ALK1 large B-cell lymphoma | |ALK1 large B-cell lymphoma | ||
| | | | ||
| | | | ||
Line 1,178: | Line 1,152: | ||
|- | |- | ||
|Plasmablastic lymphoma | |Plasmablastic lymphoma | ||
| | | | ||
| | | | ||
Line 1,208: | Line 1,181: | ||
|- | |- | ||
|[[Primary effusion lymphoma]] | |[[Primary effusion lymphoma]] | ||
| | | | ||
| | | | ||
Line 1,238: | Line 1,210: | ||
|- | |- | ||
|High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | |High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | ||
| | | | ||
| | | | ||
Line 1,294: | Line 1,265: | ||
| | | | ||
* Cutaneous manifestaions | * Cutaneous manifestaions | ||
| | | | ||
| | | | ||
Line 1,312: | Line 1,282: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
Line 1,342: | Line 1,311: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
Line 1,372: | Line 1,340: | ||
| | | | ||
|- | |- | ||
| | | | ||
| | | | ||
Line 1,436: | Line 1,403: | ||
| | | | ||
| | | | ||
* Neutropenia | |||
* Anemia | |||
* Hypergammaglobulinemia | |||
| | | | ||
| | | | ||
Line 1,446: | Line 1,416: | ||
* [[CD4]]- | * [[CD4]]- | ||
* [[CD8]]+ | * [[CD8]]+ | ||
| | | | ||
:* Clonal rearrangements of the [[T-cell receptor]] (TCR) gene | :* Clonal rearrangements of the [[T-cell receptor]] (TCR) gene | ||
Line 1,461: | Line 1,427: | ||
|- | |- | ||
|[[Subcutaneous panniculitis-like T-cell lymphoma]] | |[[Subcutaneous panniculitis-like T-cell lymphoma]] | ||
| | | | ||
| | | |
Revision as of 19:58, 28 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Mechanism | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | Imaging | |||||||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other | ||||||||||||||||||
Inherited | Acquired | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | ||||||||||||||
HL | ||||||||||||||||||||||||||||
Hodgkin's Lymphoma | ||||||||||||||||||||||||||||
NHL | ||||||||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||||||
Follicular lymphoma |
|
+ | + |
|
|
+ | ||||||||||||||||||||||
Mantle cell lymphoma |
|
|||||||||||||||||||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic:
|
|
|||||||||||||||||||
Category | Disease | Etiology | Inherited | Acquired | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | LAP | Hepatosplenomegaly | Arthritis | Other | WBC | Hb | Plt | PBS | LFT | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Imaging | Gold standard | Associated findings |
Burkitt lymphoma |
|
|
|
|
|
|||||||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
|||||||||||||||||||||||||||
Marginal zone lymphoma |
|
|||||||||||||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
|||||||||||||||||||||||||||
B cell lymphoma | Mantle cell lymphoma |
|
|
|
CBC
|
|
|
|||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
|
|
|
||||||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
||||||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
|||||||||||||||||||||||||
Plasma cell myeloma | ||||||||||||||||||||||||||||
Chronic lymphocytic leukemia / small lymphocytic lymphoma | ||||||||||||||||||||||||||||
Monoclonal B-cell lymphocytosis | ||||||||||||||||||||||||||||
B-cell prolymphocytic leukemia | ||||||||||||||||||||||||||||
Waldenström's macroglubulinemia | ||||||||||||||||||||||||||||
Monoclonal gammopathy of undetermined significance (MGUS) | ||||||||||||||||||||||||||||
Heavy chain disease | ||||||||||||||||||||||||||||
Solitary plasmacytoma of bone | ||||||||||||||||||||||||||||
Extraosseous plasmacytoma | ||||||||||||||||||||||||||||
Monoclonal immunoglobulin deposition diseases | ||||||||||||||||||||||||||||
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) | ||||||||||||||||||||||||||||
Large B-cell lymphoma with IRF4 rearrangement | ||||||||||||||||||||||||||||
Primary cutaneous follicle center lymphoma | ||||||||||||||||||||||||||||
T-cell/histiocyte-rich large B-cell lymphoma | ||||||||||||||||||||||||||||
Lymphomatoid granulomatosis | ||||||||||||||||||||||||||||
Primary mediastinal (thymic) large B-cell lymphoma | ||||||||||||||||||||||||||||
Intravascular large B-cell lymphoma | ||||||||||||||||||||||||||||
ALK1 large B-cell lymphoma | ||||||||||||||||||||||||||||
Plasmablastic lymphoma | ||||||||||||||||||||||||||||
Primary effusion lymphoma | ||||||||||||||||||||||||||||
High-grade B-cell lymphoma, with MYC and BCL2 and/or BCL6 rearrangements | ||||||||||||||||||||||||||||
T cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
||||||||||||||||||||||||
T-cell granular lymphocytic leukemia |
|
Symptoms of T-cell large granular lymphocyte leukemia may include the following: |
|
|
|
|||||||||||||||||||||||
Subcutaneous panniculitis-like T-cell lymphoma |